Click image to view it in full size

The year 2020 has been game-changing. The pandemic and other geopolitical events left many businesses in an unprecedented state of uncertainty. Healthcare companies across the care continuum were faced with new challenges, and their role and value proposition as perceived by customers is still evolving. Healthcare delivery has transformed, and the concept of “anytime anywhere care” will go mainstream as new business models emerge. The world has seen unprecedented usage of telehealth tools and a growth in adoption of Digital Health. In light of the strong growth opportunities that will emerge for healthcare stakeholders across the world region, vendors will need to redefine their visions and realign their strategies for 2021 and beyond. The Global Healthcare Outlook for 2021 outlines the landscape of key healthcare sectors - pharmaceuticals, in-vitro diagnostics, medical devices and imaging and digital health help key stakeholders strategize and identify areas of strong growth potential in the coming years.

Revenue streams of key players across the healthcare value chain was disrupted due to the pandemic last year and assessing the impact of this and understanding the emerging business models has become critical to succeed. It also identifies key companies that hold promise and must be watched out for. While we all know that digital transformation has occurred, this report highlights key predictions on specifics of this transformation along with lucrative growth opportunities for the next five years.